No headlines found.
No press releases found.
No news found.
Texas Capital Bancshares Inc is a more than $10 billion asset bank that caters to middle-market companies and wealthy people in the Lone Star State. Business loans are the biggest portfolio in the loan book, with almost 60% share, followed by commercial real estate at 30%. Construction, consumer, and leasing credits make up the balance. The bank operates in Texas' main metropolitan areas, like Austin, Dallas, Fort Worth, Houston, and San Antonio.
Texas Capital Bancshares, Inc. - Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B trades on the NASDAQ stock market under the symbol TCBIO.
As of April 1, 2025, TCBIO stock price climbed to $19.55 with 19,598 million shares trading.
TCBIO has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, TCBIO traded as high as $25.05 and as low as $12.00.
TCBIO has underperformed the market in the last year with a price return of +3.0% while the SPY ETF gained +8.7%. However, in the short term, TCBIO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +2.5% vs -3.9% return in SPY. But in the last 2 weeks, TCBIO shares have been beat by the market, returning -5.2% compared to an SPY return of -0.7%.
TCBIO support price is $19.15 and resistance is $19.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TCBIO shares will trade within this expected range on the day.